Imaging Biomarkers Market Size, Share, and Outlook, H2-2025 Report- By Technology (Positron Emission Tomography (PET), Ultrasound, Magnetic Resonance Imaging, Computed Tomography (CT), Single-Photon Emission Computerized Tomography (SPECT), Others), By Ap
Description
Imaging Biomarkers Market Outlook
The global Imaging Biomarkers Market Size is valued at $15.3 Billion in 2025 and is forecast to reach $37.8 Billion in 2032 at a CAGR of 13.8%.
The Imaging Biomarkers Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Imaging Biomarkers Market segments across 22 countries from 2021 to 2032. Key segments covered include By Technology (Positron Emission Tomography (PET), Ultrasound, Magnetic Resonance Imaging, Computed Tomography (CT), Single-Photon Emission Computerized Tomography (SPECT), Others), By Application (Personalized Medicine, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease), By Diagnosis (Forensic Applications, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Imaging Biomarkers Market Insights, 2025
The imaging biomarkers market in 2025 is witnessing strong momentum as pharmaceutical R&D increasingly incorporates advanced imaging modalities into drug development pipelines for oncology, neurology, and cardiology. The shift from traditional histopathological endpoints to imaging-derived quantitative data is enabling earlier detection of therapeutic effects and more adaptive clinical trial designs. AI-powered image analysis tools are enhancing the precision and reproducibility of biomarker measurements, fostering regulatory confidence in imaging-based endpoints. Radiomics and PET tracer development are expanding the biomarker repertoire, enabling the assessment of tumor heterogeneity, neuroinflammation, and myocardial perfusion in unprecedented detail. Academic-industry collaborations are playing a crucial role in validating these biomarkers for FDA and EMA qualification programs. Additionally, cloud-based imaging repositories and secure data-sharing frameworks are improving cross-institutional research efficiency. These advancements are solidifying imaging biomarkers as a cornerstone of precision medicine in both research and clinical practice.
Five Trends Shaping the Global Imaging Biomarkers Market in 2025 and Beyond
The global Imaging Biomarkers Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Imaging Biomarkers Industry?
The Imaging Biomarkers Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Imaging Biomarkers Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Imaging Biomarkers Market Segment Insights
The Imaging Biomarkers Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Technology (Positron Emission Tomography (PET), Ultrasound, Magnetic Resonance Imaging, Computed Tomography (CT), Single-Photon Emission Computerized Tomography (SPECT), Others), By Application (Personalized Medicine, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease), By Diagnosis (Forensic Applications, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Imaging Biomarkers Industry Value Chain
The chapter identifies potential companies and their operations across the global Imaging Biomarkers Industry ecosystem. It assists decision-makers in evaluating global Imaging Biomarkers Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Imaging Biomarkers Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Imaging Biomarkers Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Imaging Biomarkers Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Imaging Biomarkers Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Imaging Biomarkers Market.
Europe Imaging Biomarkers Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Imaging Biomarkers Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Imaging Biomarkers Industry competitiveness. The report analyses the key Imaging Biomarkers Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Imaging Biomarkers Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Imaging Biomarkers Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Imaging Biomarkers Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Imaging Biomarkers Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Imaging Biomarkers Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Imaging Biomarkers Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Bioxydyn Ltd, Brainomix Ltd, ICON Plc, Imabiotech, Invicro LLC, IXICO plc, Median Technologies, PI Solutions Group GmbH, Siemens Healthineers AG, Zionexa. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Imaging Biomarkers Market Scope
Leading Segments
By Technology
Positron Emission Tomography (PET)
Ultrasound, Magnetic Resonance Imaging
Computed Tomography (CT)
Single-Photon Emission Computerized Tomography (SPECT)
Others
By Application
Personalized Medicine
Drug Discovery and Development
Molecular Diagnostics
Drug Formulation
Disease
By Diagnosis
Forensic Applications
Others
Leading Companies
Bioxydyn Ltd
Brainomix Ltd
ICON Plc
Imabiotech
Invicro LLC
IXICO plc
Median Technologies
PI Solutions Group GmbH
Siemens Healthineers AG
Zionexa
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Imaging Biomarkers Market Size is valued at $15.3 Billion in 2025 and is forecast to reach $37.8 Billion in 2032 at a CAGR of 13.8%.
The Imaging Biomarkers Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Imaging Biomarkers Market segments across 22 countries from 2021 to 2032. Key segments covered include By Technology (Positron Emission Tomography (PET), Ultrasound, Magnetic Resonance Imaging, Computed Tomography (CT), Single-Photon Emission Computerized Tomography (SPECT), Others), By Application (Personalized Medicine, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease), By Diagnosis (Forensic Applications, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Imaging Biomarkers Market Insights, 2025
The imaging biomarkers market in 2025 is witnessing strong momentum as pharmaceutical R&D increasingly incorporates advanced imaging modalities into drug development pipelines for oncology, neurology, and cardiology. The shift from traditional histopathological endpoints to imaging-derived quantitative data is enabling earlier detection of therapeutic effects and more adaptive clinical trial designs. AI-powered image analysis tools are enhancing the precision and reproducibility of biomarker measurements, fostering regulatory confidence in imaging-based endpoints. Radiomics and PET tracer development are expanding the biomarker repertoire, enabling the assessment of tumor heterogeneity, neuroinflammation, and myocardial perfusion in unprecedented detail. Academic-industry collaborations are playing a crucial role in validating these biomarkers for FDA and EMA qualification programs. Additionally, cloud-based imaging repositories and secure data-sharing frameworks are improving cross-institutional research efficiency. These advancements are solidifying imaging biomarkers as a cornerstone of precision medicine in both research and clinical practice.
Five Trends Shaping the Global Imaging Biomarkers Market in 2025 and Beyond
The global Imaging Biomarkers Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Imaging Biomarkers Industry?
The Imaging Biomarkers Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Imaging Biomarkers Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Imaging Biomarkers Market Segment Insights
The Imaging Biomarkers Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Technology (Positron Emission Tomography (PET), Ultrasound, Magnetic Resonance Imaging, Computed Tomography (CT), Single-Photon Emission Computerized Tomography (SPECT), Others), By Application (Personalized Medicine, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease), By Diagnosis (Forensic Applications, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Imaging Biomarkers Industry Value Chain
The chapter identifies potential companies and their operations across the global Imaging Biomarkers Industry ecosystem. It assists decision-makers in evaluating global Imaging Biomarkers Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Imaging Biomarkers Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Imaging Biomarkers Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Imaging Biomarkers Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Imaging Biomarkers Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Imaging Biomarkers Market.
Europe Imaging Biomarkers Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Imaging Biomarkers Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Imaging Biomarkers Industry competitiveness. The report analyses the key Imaging Biomarkers Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Imaging Biomarkers Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Imaging Biomarkers Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Imaging Biomarkers Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Imaging Biomarkers Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Imaging Biomarkers Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Imaging Biomarkers Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Bioxydyn Ltd, Brainomix Ltd, ICON Plc, Imabiotech, Invicro LLC, IXICO plc, Median Technologies, PI Solutions Group GmbH, Siemens Healthineers AG, Zionexa. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Imaging Biomarkers Market Scope
Leading Segments
By Technology
Positron Emission Tomography (PET)
Ultrasound, Magnetic Resonance Imaging
Computed Tomography (CT)
Single-Photon Emission Computerized Tomography (SPECT)
Others
By Application
Personalized Medicine
Drug Discovery and Development
Molecular Diagnostics
Drug Formulation
Disease
By Diagnosis
Forensic Applications
Others
Leading Companies
Bioxydyn Ltd
Brainomix Ltd
ICON Plc
Imabiotech
Invicro LLC
IXICO plc
Median Technologies
PI Solutions Group GmbH
Siemens Healthineers AG
Zionexa
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
184 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Imaging Biomarkers Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Imaging Biomarkers Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Imaging Biomarkers Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Imaging Biomarkers Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Imaging Biomarkers Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Technology
- Positron Emission Tomography (PET)
- Ultrasound, Magnetic Resonance Imaging
- Computed Tomography (CT)
- Single-Photon Emission Computerized Tomography (SPECT)
- Others
- By Application
- Personalized Medicine
- Drug Discovery and Development
- Molecular Diagnostics
- Drug Formulation
- Disease
- By Diagnosis
- Forensic Applications
- Others
- 6. Global Imaging Biomarkers Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Imaging Biomarkers Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Imaging Biomarkers Market Trends and Growth Opportunities
- 6.2.1 North America Imaging Biomarkers Market Outlook by Type
- 6.2.2 North America Imaging Biomarkers Market Outlook by Application
- 6.3 North America Imaging Biomarkers Market Outlook by Country
- 6.3.1 The US Imaging Biomarkers Market Outlook, 2021- 2032
- 6.3.2 Canada Imaging Biomarkers Market Outlook, 2021- 2032
- 6.3.3 Mexico Imaging Biomarkers Market Outlook, 2021- 2032
- 7. Europe Imaging Biomarkers Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Imaging Biomarkers Market Trends and Growth Opportunities
- 7.2.1 Europe Imaging Biomarkers Market Outlook by Type
- 7.2.2 Europe Imaging Biomarkers Market Outlook by Application
- 7.3 Europe Imaging Biomarkers Market Outlook by Country
- 7.3.2 Germany Imaging Biomarkers Market Outlook, 2021- 2032
- 7.3.3 France Imaging Biomarkers Market Outlook, 2021- 2032
- 7.3.4 The UK Imaging Biomarkers Market Outlook, 2021- 2032
- 7.3.5 Spain Imaging Biomarkers Market Outlook, 2021- 2032
- 7.3.6 Italy Imaging Biomarkers Market Outlook, 2021- 2032
- 7.3.7 Russia Imaging Biomarkers Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Imaging Biomarkers Market Outlook, 2021- 2032
- 8. Asia Pacific Imaging Biomarkers Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Imaging Biomarkers Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Imaging Biomarkers Market Outlook by Type
- 8.2.2 Asia Pacific Imaging Biomarkers Market Outlook by Application
- 8.3 Asia Pacific Imaging Biomarkers Market Outlook by Country
- 8.3.1 China Imaging Biomarkers Market Outlook, 2021- 2032
- 8.3.2 India Imaging Biomarkers Market Outlook, 2021- 2032
- 8.3.3 Japan Imaging Biomarkers Market Outlook, 2021- 2032
- 8.3.4 South Korea Imaging Biomarkers Market Outlook, 2021- 2032
- 8.3.5 Australia Imaging Biomarkers Market Outlook, 2021- 2032
- 8.3.6 South East Asia Imaging Biomarkers Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Imaging Biomarkers Market Outlook, 2021- 2032
- 9. South America Imaging Biomarkers Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Imaging Biomarkers Market Trends and Growth Opportunities
- 9.2.1 South America Imaging Biomarkers Market Outlook by Type
- 9.2.2 South America Imaging Biomarkers Market Outlook by Application
- 9.3 South America Imaging Biomarkers Market Outlook by Country
- 9.3.1 Brazil Imaging Biomarkers Market Outlook, 2021- 2032
- 9.3.2 Argentina Imaging Biomarkers Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Imaging Biomarkers Market Outlook, 2021- 2032
- 10. Middle East and Africa Imaging Biomarkers Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Imaging Biomarkers Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Imaging Biomarkers Market Outlook by Type
- 10.2.2 Middle East and Africa Imaging Biomarkers Market Outlook by Application
- 10.3 Middle East and Africa Imaging Biomarkers Market Outlook by Country
- 10.3.1 Saudi Arabia Imaging Biomarkers Market Outlook, 2021- 2032
- 10.3.2 The UAE Imaging Biomarkers Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Imaging Biomarkers Market Outlook, 2021- 2032
- 10.3.4 South Africa Imaging Biomarkers Market Outlook, 2021- 2032
- 10.3.5 Egypt Imaging Biomarkers Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Imaging Biomarkers Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Bioxydyn Ltd
- Brainomix Ltd
- ICON Plc
- Imabiotech
- Invicro LLC
- IXICO plc
- Median Technologies
- PI Solutions Group GmbH
- Siemens Healthineers AG
- Zionexa
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
